DOCSLIB.ORG

RCN International Centenary Conference Book of Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

RCN International Centenary Conference Book of abstracts 22 and 23 November 2016 QEII Centre, London SW1P 3EE Sponsored by 2 Contents Main hall chair biographies 4 Wednesday 23 November 2016 66 Keynote lectures 66 Tuesday 22 November 2016 6 Keynote lectures 6 Wednesday 23 November 2016 68 Concurrent session 3 68 Theme: Society, communities, relationships 68 Tuesday 22 November 2016 8 Theme: Society, communities, relationships 70 Concurrent session 1 8 Theme: Society, communities, relationships 71 Theme: Society, communities, relationships 8 Theme: Technology and innovation 73 Theme: Society, communities, relationships 11 Theme: Knowledge for change and improvement 75 Theme: Technology and innovation 14 Theme: Knowledge for change and improvement 75 Theme: Technology and innovation 17 Theme: Knowledge for change and improvement 77 Theme: Conflicts, disaster and recovery 20 Theme: Knowledge for change and improvement 78 Theme: Conflicts, disaster and recovery 22 Theme: Knowledge for change and improvement 80 Theme: Populations, health and economic growth 25 Theme: Knowledge for change and improvement 82 Theme: Populations, health and economic growth 28 Theme: Knowledge for change and improvement 34 Theme: Knowledge for change and improvement 37 Wednesday 23 November 2016 84 Concurrent session 4 84 Theme: Societies, communities, relationships 84 Tuesday 22 November 2016 40 Theme: Societies, communities, relationships 87 Concurrent session 2 40 Theme: Society, communities, relationships 89 Theme: Society, communities, relationships 40 Theme: Technology and innovation 91 Theme: Society, communities, relationships 42 Theme: Technology and innovation 94 Theme: Technology and innovation 44 Theme: RCN Session 96 Theme: Professional development 46 Theme: Knowledge for change and improvement 98 Theme: Conflicts, disaster and recovery 47 Theme: Knowledge for change and improvement 101 Theme: Populations, health and economic growth 51 Theme: Knowledge for change and improvement 104 Theme: Populations, health and economic growth 53 Theme: Knowledge for change and improvement 108 Theme: Knowledge for change and improvement 56 Theme: Knowledge for change and improvement 110 Theme: Knowledge for change and improvement 58 Theme: Knowledge for change and improvement 61 Theme: Knowledge for change and improvement 63 Posters 114 Theme: Social event presentation 64 3 Main hall chair biographies Cecilia Anim, RCN President Christine Hancock, Director, C3 Cecilia Anim was elected President of the RCN in 2015, Collaborating for Health, UK having been a member for over 30 years, elected deputy President in 2010 and re-elected to the role in 2012. She Christine Hancock is the founder of C3 Collaborating for was also an RCN steward for 19 years and a health and Health, a global charity working to prevent chronic disease. safety representative for 17 years. She is also a member She is an experienced nurse and NHS manager. She was of the RCN’s Council Executive Team, Membership and CEO/general secretary of the Royal College of Nursing Representation Committee, International Committee, Ethics and then president of the International Council of Nurses, Committee and Awards Panel. visiting nurses in 50 countries. She has been a governor of De Montfort University and is a trustee of a charity for She has worked tirelessly supporting members in three homeless people. Christine has recently become a member central London NHS trusts. of the NHS Healthy Workforce Advisory Board, helping to Cecilia was also the staff-side secretary working in create a step change in the health of the 1.2 million NHS partnership with other unions, and secretary of her local workforce. RCN branch for 10 years. She then chaired the new branch and served on the London board before taking up the position of deputy president. In addition to these responsibilities, Cecilia previously served on the Ethics Forum Steering Committee and was also a member on the RCN Menopause Nurses Steering Group. Cecilia still coordinates the Network Group in London. In recognition of Cecilia’s contribution, she and was awarded the RCN Certificate of Merit for outstanding service to members. Cecilia works as a clinical nurse specialist in sexual and reproductive health at the Margaret Pyke Centre in London and received a long service award for over 30 year’s commitment to the NHS. Cecilia specialises in family planning and aspects of women’s health and has a particular interest in menopause and public health issues. Cecilia was awarded the Bevan award for Health and Wellbeing in 2013 and the Wise Woman of the Year Award in 2014. In 2015 Cecilia had the great honour of being receiving the United Nations African Women of Excellence award. This award celebrates and recognises the contribution of African Women or women of African descent have made to political, social and economic independence. Cecilia originally trained as a midwife in Ghana, where she worked before moving to the UK and qualifying as a nurse in 1977. Cecilia is also actively involved in the activities of her local church, where she is a member of the PCC and also arranges flowers. Furthermore, she is also Chair of Governors of her local primary school. 4 TUESDAY PROGRAMME 5 Tuesday 22 November 2016 - ConcurrentKeynote lectures session 2 Tuesday 22 November 2016 Keynote lectures 9.45 – 10.30am 11.15am – 12noon Keynote lecture 1: Title to follow Keynote lecture 2: An exciting Room Churchill Auditorium (main hall) future for nurses and nursing Speaker James Campbell, Director, Health Workforce, Room Churchill Auditorium (main hall) World Health Organization, UK Speaker Maureen Bisognano, President Emerita and Senior Fellow, Institute for Healthcare Biography Improvement, USA Jim Campbell is the Director of the Health Workforce Department at the World Health Organization (WHO) and the Executive Director of the Global Health Workforce Summary Alliance (GHWA). Prior to taking on this role in July 2014, Mr Innovation and improvement will be the tools for change Campbell was the Director of the Instituto de Cooperación for today’s nurses. In this session we will look to domestic Social Integrare (ICS Integrare), a not-for-profit research and international examples of nurses leading health care institute in Barcelona, Spain where he worked for eight transformations, and look to the next decades of change. years. Abstract He has worked as a specialist researcher/adviser on In today’s quickly changing and evolving health and health Human Resources for Health for governments, UN agencies care environment, front line teams, often led by nurses, play and philanthropic foundations, including WHO, GHWA, a crucial role in delivering the best possible care. In this UNFPA, World Bank, UK DFID, Norad and BMGF. Examples presentation we will address recent nurse-driven changes of this work include the Global Code of Practice on the in care, as well as future methods of change, and areas that International Recruitment of Health Personnel (2010), WHO should be explored. Special emphasis will be put on leading policy recommendations on Increasing access to health multigenerational, multi-professional, and multi-ethnic workers in remote and rural areas through improved retention teams, as well as addressing the changing expectations of (2010), A Universal Truth: No Health Without a Workforce patients, especially those of the younger generations. published at the Third Global Forum on HRH in Recife, Brazil (2013) and the State of the World’s Midwifery 2014 Intended learning outcomes report. • Describe the role nurses have played in transforming health care. • Identify ways nurses will improve health and care in the future. • Describe the key roles in leading multi-professional, multigenerational, and multi-ethnic teams. Reading list Bisognano M, Schummers D. Flipping healthcare. BMJ. 2014 Oct 3:349 Bisognano M, Kenney C. Pursuing the Triple Aim, Seven Innovators Show the Way to Better Care, Better Health, and Lower Costs. San Francisco: Jossey-Bass A Wiley Imprint; 2012 Biography Maureen Bisognano, President Emerita and Senior Fellow, Institute for Healthcare Improvement (IHI), previously served as IHI’s President and CEO for five years, after serving as Executive Vice President and COO for 15 years. Ms Bisognano advises health care leaders around the world, is a frequent speaker at major health care conferences on quality improvement, and is a tireless advocate for change. 6 TuesdayTuesday 22 November 22 November 2016 2016 - Concurrent - Keynote session lectures 2 She is also an Instructor of Medicine at Harvard Medical School and serves on the boards of the Commonwealth Fund, Cincinnati Children’s Hospital Medical Center, and ThedaCare Center for Healthcare Value. 12noon – 12.45pm Keynote lecture 3: Education and eliminating violence against women Room Churchill Auditorium (main hall) Speaker Dr Phumzile Mlambo-Ngcuka, Under Secretary-General and Executive Director, UN Women, USA 7 Tuesday 22 November 2016 - Concurrent session 21 Tuesday 22 November 2016 Concurrent session 1 Theme: Society, communities, understanding of the embodied experiences of our patients and our own embodiment as nurses. The paper proposes a relationships corporeal (re)turn to nursing practice, one that recognises the lived embodied experience of the patient and the embodied skill and knowledge of the nurse. It examines how 2 – 2.30pm such a corporeal (re)turn is important for contemporary person-centred practice, research and education, and for 1.1.1 Embodied practice: the rediscovery of
Recommended publications
  • National Institute for Clinical Excellence

    National Institute for Clinical Excellence

    NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus (review of TA397) [ID1591] Matrix of consultees and commentators Consultees Commentators (no right to submit or appeal) Company/sponsor General commentators • GlaxoSmithKline • All Wales Therapeutics and Toxicology Centre Patient/carer groups • Allied Health Professionals • Action for Sick Children Federation • Action on Pain • Board of Community Health Councils • Anticoagulation UK in Wales • Arthritis Action • British National Formulary • Arthritis & Musculoskeletal Alliance • Care Quality Commission • Black Health Agency • Cell and Gene Therapy Catapult • British Sjögren’s Syndrome • Department of Health, Social Services Association and Public Safety for Northern Ireland • Changing Faces • Healthcare Improvement Scotland • Contact • Hospital Information Services - • Disability Rights UK Jehovah's Witnesses • Genetic Alliance UK • Medicines and Healthcare Products • Jnetics Regulatory Agency • Kidney Care UK • National Association of Primary Care • Leonard Cheshire Disability • National Pharmacy Association • Let’s Face It • NHS Alliance • Lupus Trust • NHS Confederation • Lupus UK • NHS England Specialised • National Children's Bureau Rheumatology Clinical Reference • National Kidney Federation Group • National Rheumatoid Arthritis Society • Scottish Medicines Consortium • Pain Concern • Welsh Health Specialised Services • Pain Relief Foundation Committee • Pain UK •
  • Thrombosis Uk for the Year Ended 31 Janiiary 2016

    Thrombosis Uk for the Year Ended 31 Janiiary 2016

    THROMBOSIS UK (Formerly known as Lifeblood: The Thrombosis Charity) (A Company Limited by Guarantee) REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANIIARY 2016 Registered Charity No: 1090540 Company No: 4354472 THROMBOSIS UK Registered Charity No: 1090540 Company No: 4354472 TRUSTEES AND MANAGEMENT Trustees Shelley Anne Webster, LLB, PgDL, BVC- (Chair until 01.06.16) Dr Beverley Jane Hunt, MD, FRCP, FRCPath Simon Hart, FCCA. Kim Lesley Carter Dr Simon Noble Professor lan Maxwell Franklin (Chair from 01.06.16) Robin Offord Paul Westerman Clare Mary Reynolds Andrea Louise Croft Raanan Evelyn ZVI Gillon (Resigned on 25.06.16) Dr Matthew Robert Fay (Appointed on 20.02.15) Secretary Dr B J Hunt, MD, FRCP, FRCPath Council of Reference Professor Lesley Regan MD, FRCOG Professor E G D Tuddenham, MBBS, FRCP, FRCPath, FRCPE, MD Dr A T Cohen MBBS, MSc, MD, FRACP Registered office 91 Gower Street London WC1E 6AB Auditors Couch Bright King & Co Chartered Accountants 91 Gower Street London WC1E 6AB Solicitors Stone King 28 Ely Place London ECIN 6TD Bankers National Westminster Bank pic Maids Vale Elgin Avenue Branch 298 tlgin Avcnuc London W91WT THROMBOSIS UK Registered Charity No: 1090540 Company No: 4354472 TRUSTEES' ANNUAL REPORT FOR THE YEAR ENDED 31 JANUARY 2016 The Trustees present their report along with the financial statements of the charity for the year ended 31 January 2016. The financial statements have been prepared in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015) and follow the recommendations in Accounting and Reporting by Charities: Statement of Recommended Practice (SORP 2015).
  • Unit 3: Thematic Studies from a Broad Historical Perspective 3C

    Unit 3: Thematic Studies from a Broad Historical Perspective 3C

    UNIT 3: THEMATIC STUDIES FROM A BROAD HISTORICAL PERSPECTIVE 3C. The DevelopmentThe Voyages of Warfare, of Discovery and c.1250 to the present day.Conquest of the Americas, 1492-1522 Causes of war. Have wars always had the same causes over time? Causes of war in general. Overview “Every age had its own kind of war, its limiting conditions and its own peculiar preconceptions.” - Carl von Clausewitz (1780-1831), Prussian general and military theorist. There can be no single cause of war. The origins of conflict over time have been diverse and complex but they have basic similarities and characteristics. Political, economic, religious, nationalistic and ideological factors have been the causes of war and warfare itself has been shaped by science and technology. Recent research has revealed that there have only been 292 years without war since 3,600 BC. In ancient times nomadic peoples went to war over grazing rights and the prospects of plunder. The Roman Empire was established by warfare and ultimately destroyed by it. Religion was a major cause of war in early times while in the modern era imperialism and commercial rivalry have pushed nations to war. With causes there are consequences. The cost has been over 150 million war- related deaths of which 96% have occurred in the last 400 years. The concept of “Total War” in more recent times, where civilians become targets, has increased the death toll. In the First World War there were 8.4 million military and 1.4 million civilian deaths. In the Second World War there were 16.9 million military and 34.3 million civilian deaths.
  • Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19

    Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19

    Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Journal Pre-proof COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Behnood Bikdeli, MD, MS, Mahesh V. Madhavan, MD, David Jimenez, MD, PhD, Taylor Chuich, PharmD, Isaac Dreyfus, MD, Elissa Driggin, MD, Caroline Der Nigoghossian, PharmD, Walter Ageno, MD, Mohammad Madjid, MD, MS, Yutao Guo, MD, PhD, Liang V. Tang, MD, Yu Hu, MD, Jay Giri, MD, MPH, Mary Cushman, MD, MSc, Isabelle Quéré, MD, PhD, Evangelos P. Dimakakos, MD, C. Michael Gibson, MD, Giuseppe Lippi, MD, Emmanuel J. Favaloro, PhD, Jawed Fareed, PhD, Joseph A. Caprini, MD, MS, Alfonso J. Tafur, MD, MS, John R. Burton, BS, Dominic P. Francese, MPH, Elizabeth Y. Wang, MD, Anna Falanga, MD, Claire McLintock, MD, Beverley J. Hunt, MD, Alex C. Spyropoulos, MD, Geoffrey D. Barnes, MD, MSc, John W. Eikelboom, MBBS, Ido Weinberg, MD, Sam Schulman, MD, PhD, Marc Carrier, MD, MSc, Gregory Piazza, MD, MS, Joshua A.
  • A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically Effective and Cost-Eff

    A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically Effective and Cost-Eff

    HEALTH TECHNOLOGY ASSESSMENT VOLUME 19 ISSUE 83 OCTOBER 2015 ISSN 1366-5278 A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT) Simon I Noble, Annmarie Nelson, David Fitzmaurice, Marie-Jet Bekkers, Jessica Baillie, Stephanie Sivell, Joanna Canham, Joanna D Smith, Angela Casbard, Ander Cohen, David Cohen, Jessica Evans, Kate Fletcher, Miriam Johnson, Anthony Maraveyas, Hayley Prout and Kerenza Hood DOI 10.3310/hta19830 A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT) Simon I Noble,1,2* Annmarie Nelson,2 David Fitzmaurice,3 Marie-Jet Bekkers,4 Jessica Baillie,5 Stephanie Sivell,2 Joanna Canham,1 Joanna D Smith,1 Angela Casbard,1 Ander Cohen,6 David Cohen,7 Jessica Evans,1 Kate Fletcher,8 Miriam Johnson,9 Anthony Maraveyas,10 Hayley Prout2 and Kerenza Hood4 1Wales Cancer Trials Unit, School of Medicine, Cardiff University, Cardiff, UK 2Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, UK 3Department of Primary Care Clinical Sciences, University of Birmingham, Edgbaston, UK 4South East Wales Trials Unit, Cardiff University, Cardiff, UK 5School of Healthcare Science, Cardiff University, Cardiff, UK 6Department of Surgery

  • Using the United Kingdom Standards for Public Involvement to Evaluate

    Seddon et al. Research Involvement and Engagement (2021) 7:22 https://doi.org/10.1186/s40900-021-00264-3 METHODOLOGY Open Access Using the United Kingdom standards for public involvement to evaluate the impact of public involvement in a multinational clinical study Kathy Seddon1, Jim Elliott2,MiriamJohnson3, Clare White4, Max Watson5, Annmarie Nelson6† and Simon Noble6*† Abstract Background: The publication of the United Kingdom (UK) Standards for Public Involvement (PI) (UK Standards) in research drew a clear line in the sand regarding the importance of utilising the unique experience, skills and expertise that lay people may offer to the development, conduct and dissemination of clinical research. The UK Standards provide a benchmark which researchers should aim to achieve, yet its implementation continues to be a step wise iterative process of change management. A recent evaluation by a regional research group has suggested that our understanding of PI is enhanced through reflection on the UK Standards. We report on the utility of PI in the design, conduct and dissemination of the HIDDen study, a national, multicentre clinical study based across three UK centres. Methods: A retrospective review of PI within the HIDDen study was conducted using field notes taken by the lead author from interactions throughout their involvement as a lay representative on the study. Key members of the HIDDen study were interviewed and data analysed to explore adherence to the UK Standards. Results: There was universal support for PI across the study management group with genuine inclusivity of lay members of the committee. All six of the UK Standards were met to varying degrees.
  • The Incredible Adventures of Betsi Cadwaladr

    The Incredible Adventures of Betsi Cadwaladr

    Open Research Online The Open University’s repository of research publications and other research outputs The Incredible Adventures of Betsi Cadwaladr: ’Welsh Florence Nightingale’ or ’Munchausen in Petticoats’? An evaluation of The Autobiography of Elizabeth Davis as a historical source Student Dissertation How to cite: Jones, Gruffydd (2019). The Incredible Adventures of Betsi Cadwaladr: ’Welsh Florence Nightingale’ or ’Munchausen in Petticoats’? An evaluation of The Autobiography of Elizabeth Davis as a historical source. Student dissertation for The Open University module A329 The making of Welsh history. For guidance on citations see FAQs. c 2019 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/ Version: Redacted Version of Record Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies page. oro.open.ac.uk Gruffydd Jones 1/56 Undergraduate Dissertation The Open University A329 Gruffydd Jones, 30 May 2019 The Incredible Adventures of Betsi Cadwaladr1: ‘Welsh Florence Nightingale’ or ‘Munchausen in Petticoats’? An evaluation of The Autobiography of Elizabeth Davis as a historical source. The traveller, he, whom sea or mountain sunder From his own country, sees things strange and new; That the misjudging vulgar, which lies under The mist of ignorance, esteems untrue, Rejecting whatsoever is a wonder, Unless 'tis palpable and plain to view. Hence inexperience, as I know full well, Will yield small credence to the tale I tell. The Orlando Furioso, Canto VII.2 Word count 6,438 (Introduction to Conclusion, excluding footnotes) 1 Baptised Elizabeth Cadwaladr, she has been known variously as Elizabeth/Betsy/Betsi/Beti Cadwaladr/Cadwaladyr/Davis/Davies, and as Elizabeth David Cadwalher on her death certificate.
  • RCN Bulletin 324: February 2015

    RCN Bulletin 324: February 2015

    NHS pay offer: page 3 HANDLING COMPLAINTS NEWS DIGEST P3 CONGRESS COUNTDOWN ANALYSIS P4 SUPPORTING SURVIVORS FEATURES P10 ISSUE NO. 324 FEBRUARY 2015 NURSING COUNTS RCN GENERAL ELECTION PRIORITIES P8 ELECTIONS.RCN.ORG.UK NEWS DIGEST The RCN represents nurses and nursing, promotes excellence in practice and shapes health policies. Editors: Kim Scott/Daniel Allen Editorial: 020 7647 3627 Email: [email protected] Web: www.rcn.org.uk/bulletin Address: 20 Cavendish Square, London W1G 0RN Classified advertising Services stretched Scotland investment Tel: 020 8423 1333 Fax: 020 8872 3197 The NHS is struggling and stretched The RCN has welcomed the Scottish Email: too thinly, the RCN has said in Government’s announcement that [email protected] response to a report from the King’s £100 million is to be invested in the Fund, which found that pressures on NHS over three years to tackle Acceptance of an advertisement We must make does not constitute an A&E are causing serious knock-on delayed discharges. Theresa Fyffe, effects for other services. Waiting sure the money RCN Scotland Director (pictured), endorsement of a product, makes a difference service or company, either by times for treatment are getting longer said this is an important first step in the RCN or RCN Publishing. as the NHS struggles with demand, starting to tackle the pressures in the report says. The RCN believes hospitals. However, she warned: “It For RCN country and problems are most visible in A&E is only one element of the pressure regional contact details visit but the whole NHS is affected.
  • Annual Report and Financial Statements 31St

    Annual Report and Financial Statements 31St

    cc THROMBOSIS UK (Formerly known as Lifeblood: The Thrombosis Charity) (A Company Limited by Guarantee) REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2018 Registered Charity No: 1090540 Company No: 4354472 L3174-18 THROMBOSIS UK Registered Charity No: 1090540 Company No: 4354472 TRUSTEES' ANNUAL REPORT FOR THE YEAR ENDED 31 JANUARY 2018 REFERENCE AND ADMINISTRATION DETAILS: TRUSTEES AND MANAGEMENT Trustees Shelley Anne Webster, LLB, PgDL, BVC - Professor Beverley Jane Hunt, MD, FRCP, FRCPath Simon Hart, FCCA. Professor Simon Noble Professor Ian Maxwell Franklin Robin Offord Paul Westerman (Resigned 28.06.18) Andrea Louise Croft Dr Matthew Robert Fay Mr Shaull Watson Kinghorn (Appointed 10.01.18) Mr Stephane Jaglin (Appointed 10.0l.18) CEO Ja Jerrome Secretary Professor B J Hunt, MD, FRCP, FRCPath Registered office Shropshire House 179 Tottenham Court Road London WIT7NZ Auditors Couch Bright King & Co Chartered Accountants Shropshire House 179 Tortenharn Court Road London W1T7NZ Solicitors Stone King 28 Ely Place London ECIN 6TD Bankers National Westminster Bank pIc Maida Vale Elgin Avenue Branch 298 Elgin Avenue London W91WT 2 THROMBOSIS UK Registered Charity No: 1090540 Company No: 4354472 TRUSTEES' ANNUAL REPORT FOR THE YEAR ENDED 31 JANUARY 2018 The Trustees present their annual report together with the financial statements of the charity for the year ended 31 January 2018. The financial statements have been prepared in accordance with the accounting policies set out on pages 13 to 14 and comply with the Charities Act 20 I I, the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Memorandum and Articles of Association, Accounting and Reporting by Cbarities: Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland published on 16 July 2014 and the Companies Act 2006.
  • Across Enemy Lines: a Study of the All-Party Groups in the Parliaments of Canada, Ontario, Scotland and the United Kingdom

    Across Enemy Lines: a Study of the All-Party Groups in the Parliaments of Canada, Ontario, Scotland and the United Kingdom

    Across Enemy Lines: a Study of the All-Party Groups in the Parliaments of Canada, Ontario, Scotland and the United Kingdom by Paul E.J. Thomas A thesis submitted in conformity with the requirements for the degree of Doctorate of Philosophy Department of Political Science University of Toronto © Copyright by Paul Thomas 2016 Across Enemy Lines: a Study of the All-Party Groups in the Parliaments of Canada, Ontario, Scotland and the United Kingdom Paul E.J. Thomas Doctor of Philosophy Department of Political Science University of Toronto 2016 Abstract The Parliaments of Canada, Ontario, Scotland and the United Kingdom are now home to a growing number of informal bodies that are formed by politicians from all parties who wish to cooperate on specific policy issues or relations with other countries. Such all-party groups (APGs), which deal with topics from the steel industry to genocide prevention, work to share information, meet with stakeholders, and conduct policy studies. Most also have partnerships with external actors who support their activities. This dissertation explores why the number of APGs is rising in each jurisdiction, but also why there are relatively fewer APGs in the two Canadian cases. Using statistical analyses of APG membership patterns as well as interviews with parliamentarians, lobbyists, and journalists, it finds three main factors behind APG expansion. First, the growth of APGs has helped both parliamentarians and external actors to continue to achieve their goals despite changes in the external political environment such as rising policy complexity and increased demands from citizens. Second, APG expansion has been facilitated by the evolution and increasing modularity of the APG format, which has allowed it to be adapted to a broader range of issues and activities.
  • Fourth Assembly Legacy Report

    Fourth Assembly Legacy Report

    National Assembly for Wales Health and Social Care Committee Fourth Assembly Legacy Report March 2016 The National Assembly for Wales is the democratically elected body that represents the interests of Wales and its people, makes laws for Wales and holds the Welsh Government to account. An electronic copy of this report can be found on the National Assembly’s website: www.assembly.wales Copies of this report can also be obtained in accessible formats including Braille, large print, audio or hard copy from: Health and Social Care Committee National Assembly for Wales Cardiff Bay CF99 1NA Tel: 0300 200 6565 Email: [email protected] Twitter: @SeneddHealth © National Assembly for Wales Commission Copyright 2016 The text of this document may be reproduced free of charge in any format or medium providing that it is reproduced accurately and not used in a misleading or derogatory context. The material must be acknowledged as copyright of the National Assembly for Wales Commission and the title of the document specified. National Assembly for Wales Health and Social Care Committee Fourth Assembly Legacy Report March 2016 Committee remit The Committee was established on 22 June 2011 with a remit to examine legislation and hold the Welsh Government to account by scrutinising expenditure, administration and policy matters encompassing: the physical, mental and public health of the people of Wales, including the social care system. Matters relating to the health and wellbeing of children and young people, including their social care, sat
  • Aspirin and the Prevention of Venous Thromboembolism Following Total Joint Arthroplasty COMMONLY ASKED QUESTIONS I

    Aspirin and the Prevention of Venous Thromboembolism Following Total Joint Arthroplasty COMMONLY ASKED QUESTIONS I

    SPECIALTY UPDATE: ARTHROPLASTY Aspirin and the prevention of venous thromboembolism following total joint arthroplasty COMMONLY ASKED QUESTIONS I. Azboy, The number of arthroplasties being performed increases each year. Patients undergoing an R. Barrack, arthroplasty are at risk of venous thromboembolism (VTE) and appropriate prophylaxis has A. M. Thomas, been recommended. However, the optimal protocol and the best agent to minimise VTE F. S. Haddad, under these circumstances are not known. Although many agents may be used, there is a J. Parvizi difference in their efficacy and the risk of bleeding. Thus, the selection of a particular agent relies on the balance between the desire to minimise VTE and the attempt to reduce the risk From Rothman of bleeding, with its undesirable, and occasionally fatal, consequences. Institute, Acetylsalicylic acid (aspirin) is an agent for VTE prophylaxis following arthroplasty. Many Philadelphia, United studies have shown its efficacy in minimising VTE under these circumstances. It is States inexpensive and well-tolerated, and its use does not require routine blood tests. It is also a ‘milder’ agent and unlikely to result in haematoma formation, which may increase both the risk of infection and the need for further surgery. Aspirin is also unlikely to result in persistent wound drainage, which has been shown to be associated with the use of agents such as low-molecular-weight heparin (LMWH) and other more aggressive agents. The main objective of this review was to summarise the current evidence relating to the I. Azboy, MD, Associate efficacy of aspirin as a VTE prophylaxis following arthroplasty, and to address some of the Professor of Orthopaedic common questions about its use.